Hi Lost, while your enthusiasm would be appreciated by most Coffey shareholders, I think there might be one or two teeny flaws in your approach.
You refer to EPS for FY13 of 3.4c.
Not sure where you came by that figure, but pre-NRI NPAT was $6.2m (you need to tax effect the $10.2m restructure costs, and then add that back to the reported $1.0m loss after tax).
So that’s EPS of 2.42 cps.
Also, I think the market is always forward-looking, so it is best, I believe, to not look in the rear view mirror, as it were, but to look at prospective earnings.
And specifically, in COF’s case, one needs to focus on EV/EBITDA as the most salient valuation multiple, given the significant debt reduction underway, and the resulting “re-equisation” of the EV/EBITDA multiple.
Viewed this way, and assuming there is no EBITDA rebound in the next two years (unlikely, I would have thought, but anyway...), the Free Cash Flow generated by the company would see NIBD falling by some $20m, I expect. Assuming the EV/EBITDA multiple remains at the current undemanding level of just 4x, it means that the market cap would rise by $20m, which is 25% up on the current $77m.
Of course, one would reasonably expect that, as the debt falls, the lower financial risk means that the multiple would rise (a fundamental tenet of investing).
5x EV/EBITDA would yield a share price of 40cps
6x EV/EBITDA would result in a price of 50c
And all this ignores any recovery whatsoever in operating earnings.
Cam
cup and handle breakout - packer buys in, page-16
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COF (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online